Effects of Delaying FK506 Administration on Neuroregeneration in a Rodent Model

 

 Buy Article Permissions and Reprints

ABSTRACT

FK506 is an immunosuppressant drug that has been shown experimentally to stimulate nerve growth and speed functional recovery, when administered immediately after peripheral nerve injury. However, the clinical scenario of a peripheral nerve injury is often associated with either a delayed diagnosis or reconstruction. The purpose of this study was to determine the efficacy of FK506 on neuroregeneration with delayed administration. Thirty-two Lewis rats underwent tibial nerve transection with immediate repair. Animals were left untreated, or were treated with daily injections of FK506 (2 mg/kg), started on the day of surgery, postoperative day 3, or postoperative day 5. Animals underwent walking track analysis to assess functional nerve recovery. Nerves were harvested for histomorphometric analysis on postoperative days 21, 28, and 42. Histomorphometry demonstrated that all treatment groups, regardless of the time of drug initiation, demonstrated evidence of enhanced neuroregeneration, compared to the untreated group. Histomorphometric data from groups harvested on day 21 demonstrated a statistically significant improvement in neuroregeneration in the immediate and 3-day delay groups. Therefore, the beneficial effects of FK506 on neuroregeneration are not restricted to immediate administration, but these effects significantly diminish when FK506 is administered 3 days after nerve injury.

REFERENCES

• 1 Kobayashi J, Mackinnon S E, Watanabe O. et al . The effect of duration of muscle denervation on functional recovery in the rat model.  Muscle Nerve . 1997;  20 858-866
  CrossrefPubMedGoogle Scholar
• 2 Doolabh V, Mackinnon S E. FK506 accelerates functional recovery following nerve grafting in a rat model.  Plast Reconstr Surg . 1999;  103 1928-1935
  CrossrefPubMedGoogle Scholar
• 3 Gold B G, Storm-Dickerson T, Austin D R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury.  Restor Neurol Neurosci . 1994;  6 287-296
  PubMedGoogle Scholar
• 4 Gold B G, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve.  J Neurosci . 1995;  15 7509-7516
  PubMedGoogle Scholar
• 5 Jost S C, Doolabh V, Lee M, Hunter D, Mackinnon S E. Acceleration of peripheral nerve regeneration following FK506 administration.  Restor Neurol Neurosci . 2000;  17 1-6
  PubMedGoogle Scholar
• 6 Hare G MT, Evans P J, Mackinnon S E. et al . Walking track analysis: a long-term assessment of peripheral nerve recovery.  Plast Reconstr Surg . 1992;  89 251-258
  CrossrefPubMedGoogle Scholar
• 7 Schreiber S L, Crabtree G R. The mechanism of action of cyclosporine A and FK506.  Immunol Today . 1992;  13 136-142
  CrossrefPubMedGoogle Scholar
• 8 Lee M, Doolabh V B, Mackinnon S E, Jost S. FK506 promotes functional recovery in crushed rat sciatic nerve.  Muscle Nerve . 2000;  23 633-640
  CrossrefPubMedGoogle Scholar
• 9 Sabatini D M, Lai M M, Snyder S H. Neural roles of immunophilins and their ligands.  Molec Neurobiol . 1997;  15 223-239
  PubMedGoogle Scholar
• 10 Dawson T M, Steiner J P, Lyons W E. et al . The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin.  Neuroscience . 1994;  62 569-580
  CrossrefPubMedGoogle Scholar
• 11 Spies J M, Westland K W, Bonner J G, Pollard J D. Intraneural activated T cells cause focal breakdown of the blood nerve barrier.  Brain . 1995;  118 857-868
  PubMedGoogle Scholar
• 12 Lyons W E, Steiner J P, Snyder S H, Dawson T M. Neuronal regeneration enhances the expression of the immunophilin FKBP-12.  J Neurosci . 1995;  15 2985-2994
  PubMedGoogle Scholar
• 13 Gold B G, Yew J Y, Zeleny-Pooley M. The immunosuppressant FK506 increases GAP-43 mRNA levels in axotomized sensory neurons.  Neurosci Let . 1998;  241 25-28
  CrossrefPubMedGoogle Scholar
• 14 Skene J H, Virag I. Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43.  J Cell Biology . 1989;  108 613-624
  CrossrefPubMedGoogle Scholar
• 15 Benowitz L I, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity.  Trends Neurosci . 1997;  20 84-91
  CrossrefPubMedGoogle Scholar
• 16 Kater S B, Mills L B. Regulation of growth cone behavior by calcium.  J Neurosci . 1991;  11 891
  PubMedGoogle Scholar
• 17 Cameron A M, Steiner J P, Roskams A J. et al . Calcineurin associated with the inositol 1,4,5-triphosphate receptor-FKBP12 complex modulates Ca2+ flux.  Cell . 1995;  83 463-472
  CrossrefPubMedGoogle Scholar
• 18 Takei K, Jay D G, Mikoshiba K. Regional laser inactivation of type 1 inositol 1,4,5-triphosphate receptor affects growth cone morphology and motility in chick DRG neurons.  Soc Neurosci Abstracts . 1996;  22 740
  PubMedGoogle Scholar
• 19 Gold B G, Zeleny-Pooley M, Wang M-S, Chaturvedi P, Armistead D M. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration.  Experi Neurol . 1997;  147 269-278
  PubMedGoogle Scholar
• 20 Steiner J P, Hamilton G S, Ross D T. et al . Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.  Proceed Nat Acad Sci USA . 1997;  94 2019-2024
  CrossrefPubMedGoogle Scholar
• 21 Gold B G, Densmore V, Shou W. et al . Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506.  J Pharmacol Experiment Therapeut . 1999;  289 1202-1210
  PubMedGoogle Scholar
• 22 Gold B G, Storm-Dickerson T, Austin D R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury.  Restorative Neurol Neurosci . 1994;  6 287-296
  PubMedGoogle Scholar
• 23 Doolabh V, Mackinnon S E. FK506 accelerates functional recovery following nerve grafting in a rat model.  Plast Reconstr Surg . 1999;  103 1928-1935
  CrossrefPubMedGoogle Scholar
• 24 Gold B G, Gordon H S, Wang M-S. Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect.  Neurosci Let . 1999;  267 33-36
  CrossrefPubMedGoogle Scholar
• 25 Sulaiman O AR, Voda J, Gold B G, Gordon T. FK506 increases nerve regeneration after chronic motoneuron axotomy but not after chronic Schwann cell denervation.  Experimental Neurology . 2002;  175 127-137
  CrossrefPubMedGoogle Scholar